APA

Kawano N., Kuriyama T., Sonoda K., Yoshida S., Yamashita K., Ochiai H., Shimoda K., Ishikawa F., Ueda A. & Kikuchi I. (20170327). Clinical Impact of a Humanized CCR4 Antibody (Mogamulizumab) in 14 Patients with Aggressive Adult T-cell Leukemia-lymphoma Treated at a Single Institution During a Three-year Period (2012-2014). : Internal medicine (Tokyo, Japan).

Chicago

Kawano Noriaki, Kuriyama Takuro, Sonoda Koh-Hei, Yoshida Shuro, Yamashita Kiyoshi, Ochiai Hidenobu, Shimoda Kazuya, Ishikawa Fumihiko, Ueda Akira and Kikuchi Ikuo. 20170327. Clinical Impact of a Humanized CCR4 Antibody (Mogamulizumab) in 14 Patients with Aggressive Adult T-cell Leukemia-lymphoma Treated at a Single Institution During a Three-year Period (2012-2014). : Internal medicine (Tokyo, Japan).

Harvard

Kawano N., Kuriyama T., Sonoda K., Yoshida S., Yamashita K., Ochiai H., Shimoda K., Ishikawa F., Ueda A. and Kikuchi I. (20170327). Clinical Impact of a Humanized CCR4 Antibody (Mogamulizumab) in 14 Patients with Aggressive Adult T-cell Leukemia-lymphoma Treated at a Single Institution During a Three-year Period (2012-2014). : Internal medicine (Tokyo, Japan).

MLA

Kawano Noriaki, Kuriyama Takuro, Sonoda Koh-Hei, Yoshida Shuro, Yamashita Kiyoshi, Ochiai Hidenobu, Shimoda Kazuya, Ishikawa Fumihiko, Ueda Akira and Kikuchi Ikuo. Clinical Impact of a Humanized CCR4 Antibody (Mogamulizumab) in 14 Patients with Aggressive Adult T-cell Leukemia-lymphoma Treated at a Single Institution During a Three-year Period (2012-2014). : Internal medicine (Tokyo, Japan). 20170327.